English | 繁體

Search in the results

UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Inactivation of endothelial ADAM17 reduces retinal ischemia-reperfusion induced neuronal and vascular damage Journal article
Gutsaeva,Diana R., Shalaby,Lamiaa, Powell,Folami L., Thounaojam,Menaka C., Abouhish,Hossameldin, Wetzstein,Sara A., Jadeja,Ravirajsinh N., Kwok,Hang Fai, Martin,Pamela M., Bartoli,Manuela. Inactivation of endothelial ADAM17 reduces retinal ischemia-reperfusion induced neuronal and vascular damage[J]. International Journal of Molecular Sciences, 2020, 21(15), 1-18.
Authors:  Gutsaeva,Diana R.;  Shalaby,Lamiaa;  Powell,Folami L.;  Thounaojam,Menaka C.;  Abouhish,Hossameldin; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:4.9/5.6 | Submit date：2021/03/04
Retinal Ischemia-reperfusion  Adam17  Vascular Permeability  Neuronal And Vascular Degeneration  
Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neurona and Vascularl Damage Journal article
Gutsaeva, D. R., Shalaby, L., Powell, F. L., Thounaojam, M., Abouhish , H., Wetzstein , S. A., Jadeja, R. N., Kwok, H. F., Martin, P.M., Bartoli, M.. Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neurona and Vascularl Damage[J]. International Journal of Molecular Sciences, 2020, 5379---.
Authors:  Gutsaeva, D. R.;  Shalaby, L.;  Powell, F. L.;  Thounaojam, M.;  Abouhish , H.; et al.
Favorite |   IF:4.9/5.6 | Submit date：2022/06/02
retina  ischemia-reperfusion  ADAM17  vascular permeability  neuro-vascular degeneration  
Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neurovascular Abnormalities Conference paper
Gutsaeva, D., Shalaby, L., Wetzstein, S., Thounaojam, M., Jadeja, R., Powell, F. L., Martin, P. M., Kwok, H. F., Bartoli , M.. Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neurovascular Abnormalities[C], Rockville, MD:The Association for Research in Vision and Ophthalmology (ARVO),, 2020, 1785---.
Authors:  Gutsaeva, D.;  Shalaby, L.;  Wetzstein, S.;  Thounaojam, M.;  Jadeja, R.; et al.
Favorite |  | Submit date：2022/06/02
ADAM17  ischemia-reperfusion (IR)  
Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo Conference paper
Ye, Jie, Yuen, Shun Ming, Murphy, Gillian, Xie, Ruiyu, Kwok, Hang Fai. Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo[C], PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS:ELSEVIER SCIENCE BV, 2017, 62-69.
Authors:  Ye, Jie;  Yuen, Shun Ming;  Murphy, Gillian;  Xie, Ruiyu;  Kwok, Hang Fai
Favorite | TC[WOS]:22 TC[Scopus]:23 | Submit date：2018/10/31
Pancreatic Ductal Adenocarcinoma (Pdac)  Adam17  Inhibitory Antibody  Tumorigenesis  Targeted Therapy  
Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo Journal article
Ye J., Yuen S.M., Murphy G., Xie R., Kwok H.F.. Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 antibody in a pancreatic cancer model in vivo[J]. European Journal of Pharmaceutical Sciences, 2017, 110, 62-69.
Authors:  Ye J.;  Yuen S.M.;  Murphy G.;  Xie R.;  Kwok H.F.
Favorite | TC[WOS]:22 TC[Scopus]:23  IF:4.3/4.2 | Submit date：2018/12/19
Adam17  Inhibitory Antibody  Pancreatic Ductal Adenocarcinoma (Pdac)  Targeted Therapy  Tumorigenesis  
Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17 Journal article
Ye, J., Yuen, S. M., Murphy, G., Xie, R., Kwok, H. F.. Anti-tumor effects of a ‘human & mouse cross-reactive’ anti-ADAM17[J]. European Journal of Pharmaceutical Sciences, 2017, 62-69.
Authors:  Ye, J.;  Yuen, S. M.;  Murphy, G.;  Xie, R.;  Kwok, H. F.
Favorite |   IF:4.3/4.2 | Submit date：2022/06/02
Pancreatic Ductal Adenocarcinoma (Pdac)  Adam17  Inhibitory Antibody  Tumorigenesis  Targeted Therapy  
Vascular ADAM17 Mediates Organ Damage by Angiotensin II Report
2016
Authors:  Satoru , E.;  Kwok, H. F.
Favorite |  | Submit date：2022/06/02
Vascular ADAM17  Angiotensin II  ADAM17 inhibitory monoclonal antibody A9(B8)  
Regulation of retinal blood barrier by TNF alpha convertase, ADAM17, and its implication in diabetic macular edema Conference paper
Gutsaeva, D., Hussein, K., Lamoke, F., Kwok, H. F., Solomon, A., Martin, P. M., Al-Shabrawey, M. A., Bartoli, M.. Regulation of retinal blood barrier by TNF alpha convertase, ADAM17, and its implication in diabetic macular edema[C], Rockville, MD:The Association for Research in Vision and Ophthalmology, 2016, 3226---.
Authors:  Gutsaeva, D.;  Hussein, K.;  Lamoke, F.;  Kwok, H. F.;  Solomon, A.; et al.
Favorite |  | Submit date：2022/06/02
ADAM17/TACE  diabetic macular edema and DR  
Targeting the sheddase activity of Adam17 by an Anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation Journal article
Huang Y., Benaich N., Tape C., Kwok H.F., Murphy G.. Targeting the sheddase activity of Adam17 by an Anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation[J]. International Journal of Biological Sciences, 2014, 10(7), 702-714.
Authors:  Huang Y.;  Benaich N.;  Tape C.;  Kwok H.F.;  Murphy G.
Favorite | TC[WOS]:38 TC[Scopus]:44 | Submit date：2018/12/19
Adam17  Cell Proliferation And Motility  Her Receptor And ligAnds  Inhibitory Antibody